nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP2D6—Parkinson's disease	0.847	1	CbGaD
Palonosetron—HTR3A—enteric nervous system—Parkinson's disease	0.0411	0.398	CbGeAlD
Palonosetron—HTR3A—myenteric nerve plexus—Parkinson's disease	0.0311	0.301	CbGeAlD
Palonosetron—HTR3A—nerve—Parkinson's disease	0.00811	0.0785	CbGeAlD
Palonosetron—Praziquantel—CYP2D6—Parkinson's disease	0.0054	1	CrCbGaD
Palonosetron—HTR3A—brainstem—Parkinson's disease	0.00348	0.0337	CbGeAlD
Palonosetron—HTR3A—forebrain—Parkinson's disease	0.00336	0.0325	CbGeAlD
Palonosetron—CYP2D6—hindbrain—Parkinson's disease	0.00223	0.0216	CbGeAlD
Palonosetron—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.0022	0.0498	CbGpPWpGaD
Palonosetron—HTR3A—head—Parkinson's disease	0.00192	0.0186	CbGeAlD
Palonosetron—HTR3A—nervous system—Parkinson's disease	0.00182	0.0176	CbGeAlD
Palonosetron—HTR3A—central nervous system—Parkinson's disease	0.00176	0.017	CbGeAlD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00171	0.0387	CbGpPWpGaD
Palonosetron—HTR3A—brain—Parkinson's disease	0.00139	0.0135	CbGeAlD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00129	0.0293	CbGpPWpGaD
Palonosetron—CYP2D6—brainstem—Parkinson's disease	0.00128	0.0124	CbGeAlD
Palonosetron—HTR3A—Ion channel transport—ATP1A3—Parkinson's disease	0.00126	0.0285	CbGpPWpGaD
Palonosetron—HTR3A—Ion channel transport—TRPM7—Parkinson's disease	0.00126	0.0285	CbGpPWpGaD
Palonosetron—CYP2D6—forebrain—Parkinson's disease	0.00124	0.0119	CbGeAlD
Palonosetron—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000865	0.0196	CbGpPWpGaD
Palonosetron—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000859	0.0195	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.000808	0.0183	CbGpPWpGaD
Palonosetron—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.000792	0.018	CbGpPWpGaD
Palonosetron—CYP1A2—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.000792	0.0179	CbGpPWpGaD
Palonosetron—CYP2D6—head—Parkinson's disease	0.000707	0.00684	CbGeAlD
Palonosetron—CYP3A4—nervous system—Parkinson's disease	0.000681	0.00659	CbGeAlD
Palonosetron—CYP2D6—nervous system—Parkinson's disease	0.00067	0.00649	CbGeAlD
Palonosetron—CYP3A4—central nervous system—Parkinson's disease	0.000656	0.00635	CbGeAlD
Palonosetron—CYP1A2—Methylation—COMT—Parkinson's disease	0.000651	0.0147	CbGpPWpGaD
Palonosetron—CYP2D6—central nervous system—Parkinson's disease	0.000646	0.00625	CbGeAlD
Palonosetron—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000637	0.0144	CbGpPWpGaD
Palonosetron—CYP2D6—cerebellum—Parkinson's disease	0.000631	0.0061	CbGeAlD
Palonosetron—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.000611	0.0138	CbGpPWpGaD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00059	0.0134	CbGpPWpGaD
Palonosetron—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000566	0.0128	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000544	0.0123	CbGpPWpGaD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000539	0.0122	CbGpPWpGaD
Palonosetron—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000533	0.0121	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000523	0.0119	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000516	0.0117	CbGpPWpGaD
Palonosetron—CYP2D6—brain—Parkinson's disease	0.000512	0.00496	CbGeAlD
Palonosetron—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000512	0.0116	CbGpPWpGaD
Palonosetron—CYP1A2—Xenobiotics—CYP2D6—Parkinson's disease	0.000493	0.0112	CbGpPWpGaD
Palonosetron—CYP1A2—Estrogen metabolism—NQO1—Parkinson's disease	0.000485	0.011	CbGpPWpGaD
Palonosetron—CYP1A2—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000474	0.0107	CbGpPWpGaD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000455	0.0103	CbGpPWpGaD
Palonosetron—CYP1A2—Xenobiotics—CYP2E1—Parkinson's disease	0.000451	0.0102	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000451	0.0102	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000437	0.00991	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000437	0.00991	CbGpPWpGaD
Palonosetron—CYP1A2—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000434	0.00983	CbGpPWpGaD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000416	0.00943	CbGpPWpGaD
Palonosetron—CYP1A2—Estrogen metabolism—COMT—Parkinson's disease	0.000407	0.00921	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—DDC—Parkinson's disease	0.000405	0.00917	CbGpPWpGaD
Palonosetron—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000381	0.00862	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00038	0.00862	CbGpPWpGaD
Palonosetron—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000375	0.00849	CbGpPWpGaD
Palonosetron—CYP1A2—Estrogen metabolism—GSTM1—Parkinson's disease	0.000372	0.00843	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000367	0.00832	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.000366	0.0083	CbGpPWpGaD
Palonosetron—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000366	0.00829	CbGpPWpGaD
Palonosetron—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000348	0.00789	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.000341	0.00772	CbGpPWpGaD
Palonosetron—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000335	0.00759	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000326	0.00738	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000326	0.00737	CbGpPWpGaD
Palonosetron—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000314	0.00711	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000313	0.00708	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00031	0.00703	CbGpPWpGaD
Palonosetron—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00031	0.00701	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000303	0.00687	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000295	0.00669	CbGpPWpGaD
Palonosetron—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000287	0.0065	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000276	0.00625	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000264	0.00597	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000263	0.00596	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000257	0.00582	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000247	0.00559	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000232	0.00526	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000232	0.00525	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00023	0.00522	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.000229	0.00519	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.000229	0.00519	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000228	0.00516	CbGpPWpGaD
Palonosetron—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.000228	0.00516	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000223	0.00506	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000221	0.00501	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000218	0.00494	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000214	0.00484	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000209	0.00473	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000205	0.00464	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000202	0.00458	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000187	0.00424	CbGpPWpGaD
Palonosetron—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000187	0.00423	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000185	0.00419	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000184	0.00416	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000183	0.00415	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000179	0.00406	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000179	0.00405	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000178	0.00403	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000172	0.00391	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000166	0.00376	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000158	0.00358	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000157	0.00356	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000157	0.00356	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000156	0.00353	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000155	0.00351	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000152	0.00345	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000152	0.00344	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000148	0.00334	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000146	0.00331	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000145	0.00328	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000143	0.00323	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.00014	0.00317	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000133	0.00302	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.000133	0.00302	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000131	0.00298	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000128	0.0029	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000127	0.00288	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000125	0.00283	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000122	0.00276	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000119	0.00269	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000117	0.00266	CbGpPWpGaD
Palonosetron—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000114	0.00259	CbGpPWpGaD
Palonosetron—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000114	0.00258	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000108	0.00244	CbGpPWpGaD
Palonosetron—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000105	0.00237	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000103	0.00233	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000101	0.0023	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	9.64e-05	0.00218	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	9.52e-05	0.00216	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.39e-05	0.00213	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	9.21e-05	0.00209	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	9.16e-05	0.00208	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	8.82e-05	0.002	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.7e-05	0.00197	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	8.07e-05	0.00183	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.96e-05	0.0018	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—COMT—Parkinson's disease	7.89e-05	0.00179	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	7.85e-05	0.00178	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	7.84e-05	0.00178	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	7.78e-05	0.00176	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	7.75e-05	0.00175	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.38e-05	0.00167	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.22e-05	0.00164	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.12e-05	0.00161	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.81e-05	0.00154	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.71e-05	0.00152	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—COMT—Parkinson's disease	6.69e-05	0.00151	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	6.68e-05	0.00151	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	6.68e-05	0.00151	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	6.65e-05	0.00151	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	6.64e-05	0.0015	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	6.59e-05	0.00149	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	6.56e-05	0.00149	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.23e-05	0.00141	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.14e-05	0.00139	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	6.11e-05	0.00139	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	6.03e-05	0.00137	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.16e-05	0.00117	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.14e-05	0.00116	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.12e-05	0.00116	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.12e-05	0.00116	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ND3—Parkinson's disease	5.12e-05	0.00116	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.09e-05	0.00115	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.06e-05	0.00115	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.81e-05	0.00109	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—OMD—Parkinson's disease	4.81e-05	0.00109	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.72e-05	0.00107	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.65e-05	0.00105	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.6e-05	0.00104	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.56e-05	0.00103	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.35e-05	0.000986	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ND3—Parkinson's disease	4.34e-05	0.000982	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MCCC1—Parkinson's disease	4.34e-05	0.000982	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—OMD—Parkinson's disease	4.08e-05	0.000923	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—TALDO1—Parkinson's disease	4.08e-05	0.000923	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GBA—Parkinson's disease	3.88e-05	0.000879	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.88e-05	0.000879	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—DBH—Parkinson's disease	3.88e-05	0.000879	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	3.86e-05	0.000875	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.69e-05	0.000835	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.35e-05	0.000758	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ND3—Parkinson's disease	3.35e-05	0.000758	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.32e-05	0.000753	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GBA—Parkinson's disease	3.29e-05	0.000744	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—FBP1—Parkinson's disease	3.29e-05	0.000744	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—DBH—Parkinson's disease	3.29e-05	0.000744	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.15e-05	0.000713	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—OMD—Parkinson's disease	3.15e-05	0.000713	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.98e-05	0.000676	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—DDC—Parkinson's disease	2.85e-05	0.000645	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.84e-05	0.000644	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.69e-05	0.000609	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GBA—Parkinson's disease	2.54e-05	0.000574	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.54e-05	0.000574	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—DBH—Parkinson's disease	2.54e-05	0.000574	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.42e-05	0.000548	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—DDC—Parkinson's disease	2.41e-05	0.000546	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.4e-05	0.000543	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.28e-05	0.000516	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.25e-05	0.000509	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.05e-05	0.000464	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.03e-05	0.00046	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.93e-05	0.000438	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—DDC—Parkinson's disease	1.86e-05	0.000422	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.76e-05	0.000398	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.75e-05	0.000396	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.63e-05	0.000369	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.61e-05	0.000365	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—TH—Parkinson's disease	1.59e-05	0.00036	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.58e-05	0.000358	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.57e-05	0.000355	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.52e-05	0.000345	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.51e-05	0.000342	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.48e-05	0.000335	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.38e-05	0.000313	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.36e-05	0.000309	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—COMT—Parkinson's disease	1.35e-05	0.000306	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—TH—Parkinson's disease	1.34e-05	0.000305	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.34e-05	0.000304	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.34e-05	0.000304	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.32e-05	0.0003	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.29e-05	0.000292	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.27e-05	0.000288	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.23e-05	0.00028	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.18e-05	0.000268	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.16e-05	0.000264	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—COMT—Parkinson's disease	1.14e-05	0.000259	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.14e-05	0.000259	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.14e-05	0.000258	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.14e-05	0.000257	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.12e-05	0.000254	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.09e-05	0.000247	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.08e-05	0.000244	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.06e-05	0.000241	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.05e-05	0.000239	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.05e-05	0.000237	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—TH—Parkinson's disease	1.04e-05	0.000235	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOE—Parkinson's disease	1.02e-05	0.00023	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GPX1—Parkinson's disease	1e-05	0.000227	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.96e-06	0.000226	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MTHFR—Parkinson's disease	9.24e-06	0.000209	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—COMT—Parkinson's disease	8.82e-06	0.0002	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.78e-06	0.000199	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.76e-06	0.000198	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—INS—Parkinson's disease	8.68e-06	0.000197	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMOX1—Parkinson's disease	8.66e-06	0.000196	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOE—Parkinson's disease	8.6e-06	0.000195	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.31e-06	0.000188	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.07e-06	0.000183	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.73e-06	0.000175	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—INS—Parkinson's disease	7.35e-06	0.000166	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.13e-06	0.000162	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOE—Parkinson's disease	6.64e-06	0.00015	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—INS—Parkinson's disease	5.67e-06	0.000128	CbGpPWpGaD
